Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Oct 7, 2016; 22(37): 8382-8388
Published online Oct 7, 2016. doi: 10.3748/wjg.v22.i37.8382
Table 1 Clinical characteristics and laboratory data of enrolled patients
Age80 yrAge < 80 yrP value
(n = 102)(n = 105)
Age (yr)85 (81-92)67 (58-75)< 0.05
Sex
Male41 (40.2)62 (59.0)< 0.05
Female61 (59.8)43 (41.0)
Fever (centigrade)39.0 (38.5-39.3)38.9 (38.7-39.4)NS
WBC (103/L)12.8 (10.4-15.2)12.5 (10.7-14.6)NS
Platelet (103/L)132 (105-180)171 (130-231)< 0.05
Albumin (g/dL)2.9 (2.6-3.3)3.6 (3.4-4.0)< 0.05
Bilirubin (mg/dL)4.3 (3.1-6.0)4.2 (2.8-6.7)NS
AST (U/L)229 (150-418)182 (141-256)< 0.05
ALT (U/L)195 (128-277)197 (144-303)NS
ALP (U/L)798 (576-1154)811 (510-1175)NS
γ-GTP (U/L)336 (256-451)350 (249-548)NS
ASA
Class 234 (33.3)59 (56.2)< 0.05
Class 367 (65.7)45 (42.9)
Class 41 (1.0)1 (1.0)
Table 2 Comorbidities of patients with acute cholangitis n (%)
Age80 yrAge < 80 yrP value
(n = 102)(n = 105)
Comorbidity93 (91.2)71 (67.6)< 0.05
Hypertension80 (78.4)53 (50.5)< 0.05
Ischemic heart disease40 (39.2)18 (17.1)< 0.05
Chronic heart failure8 (7.8)6 (5.7)NS
Arrhythmia17 (16.7)14 (13.3)NS
Cerebrovascular disease30 (29.4)10 (9.5)< 0.05
Dementia23 (22.5)4 (3.8)< 0.05
Diabetes mellitus21 (20.6)19 (18.1)NS
Chronic liver disease9 (8.8)8 (7.6)NS
Liver cirrhosis3 (2.9)3 (2.9)NS
COPD/Asthma15 (14.7)7 (6.7)< 0.05
Chronic renal failure5 (4.9)4 (3.8)NS
Malignancy18 (7.8)3 (2.9)< 0.05
Periampullary diverticulum25 (24.5)14 (13.3)< 0.05
Table 3 Etiology of acute cholangitis n (%)
Age80 yrAge < 80 yrP value
(n = 102)(n = 105)
CBD stone65 (63.7)72 (68.6)NS
Gallstone cholecystitis2 (2.0)4 (3.8)NS
Pancreatitis1 (1.0)2 (1.9)NS
Malignant obstruction31 (30.4)23 (21.9)< 0.05
Pancreatic cancer4 (3.9)5 (4.8)NS
Biliary cancer21 (20.6)11 (10.5)< 0.05
GB cancer3 (2.9)4 (3.8)NS
Other cause13 (2.9)3 (2.9)NS
Benign stricture3 (2.9)4 (3.8)NS
Table 4 Procedural details of endoscopic retrograde cholangiopancreatography n (%)
Age ≥ 80 yrAge < 80 yrP value
(n = 102)(n = 105)
Details of the procedure
Biliary stent insertion97 (95.1)100 (95.2)NS
Endoscopic sphincterotomy69 (67.6)87 (82.9)< 0.05
Complete stone removal53/651 (81.5)67/722 (93.1)< 0.05
Technical success397 (95.1)100 (95.2)NS
Procedures time (min), mean ± SD37.6 ± 8.140.1 ± 7.7NS
Failed cannulation5 (4.9)5 (4.8)NS
Table 5 Endoscopic retrograde cholangiopancreatography-related complications n (%)
Age ≥ 80 yrAge < 80 yrP value
(n = 102)(n = 105)
Total7 (6.9)7 (6.7)NS
Bleeding after EST3 (2.9)2 (1.9)NS
Post-ERCP pancreatitis1 (1.0)4 (3.8)< 0.05
Aggravation of cholangitis2 (2.0)1 (1.0)NS
Aspiration pneumonia1 (1.0)1 (1.0)NS
Mortality00NA
Table 6 Cardiorespiratory suppression during endoscopic retrograde cholangiopancreatography under moderate sedation n (%)
Age80 yrAge < 80 yrP value
(n = 102)(n = 105)
Total9 (8.8)8 (7.6)NS
Hypoxemia2 (2.0)2 (1.9)NS
Bradycardia4 (3.9)4 (3.8)NS
Hypotension5 (4.9)4 (3.8)NS